CrownBio Launches New Humanized Target Model for Immunotherapy

NEXT STORY
Corvus Pharmaceuticals Announces Initiation of Phase 1/1b Clinical Trial of Investigational Anti-CD73 Antibody, CPI-006, in Patients with Advanced Cancer
PREV STORY
eFFECTOR Publishes the Design and Profile of eFT508 in Peer Reviewed Journal of Medicinal Chemistry
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Spero Therapeutics Announces Positive Top-Line Data for Two Product Candidates from its Potentiator Platform

SPR741 Phase 1b Drug-Drug Interaction Study and SPR206 IND-enabling Studies Provide Support for Further ...

author_avatar
NASDAQ Market News

Dermira to Present at Cowen and Company 36th Annual Health Care Conference

MENLO PARK, Calif., March 01, 2016 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares

FIT Biotech Oy Company release May 30, 2017 at 10:00 AM EET Conversion of ...

author_avatar
NASDAQ Market News